Additionally, we found that patients with NCT‐NSCLC with high naïve CD4+TIL levels had shorter OS than those with low naïve CD4+TIL levels, and an opposite phenomenon was observed post‐chemotherapy (p = 0.069). Here, CD4 is linked to non-small cell lung carcinoma.